Halozyme Therapeutics Inc (NASDAQ:HALO)

45.04
Delayed Data
As of 3:59pm ET
 -0.09 / -0.20%
Today’s Change
31.36
Today|||52-Week Range
52.98
+12.01%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close45.13
Today’s open45.29
Day’s range44.08 - 45.51
Volume25,420
Average volume (3 months)1,113,562
Market cap$6.7B
Data as of 3:59pm ET, 08/08/2022

Growth & Valuation

Earnings growth (last year)+202.13%
Earnings growth (this year)-26.34%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+65.67%
P/E ratio15.1
Price/Sales13.32
Price/Book33.81

Competitors

----
CRSPCRISPR Therapeutics ...-0.01-0.01%
ARWRArrowhead Pharmaceut...+1.07+2.33%
NTLAIntellia Therapeutic...+0.24+0.38%
Data as of 4:00pm ET, 08/08/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)$0.47
Annual revenue (last year)$443.3M
Annual profit (last year)$402.7M
Net profit margin90.84%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts